Select Medical reports Q1 2024 revenue $1.79B (+7.4%), adj EPS $0.77 (+37.5%); declares $0.125 dividend; updates outlook

SELECT MEDICAL HOLDINGS CORP

2024-Q1 EPS reported $0.75 revenue$1,788,809,000

Revenue $1,788.8M (+7.4% YoY); net income $117.2M (+37.4%); GAAP EPS $0.75 (+33.9%).
Adjusted EPS $0.77 (+37.5% YoY); Adjusted EBITDA $261.9M (+22.4% YoY).
Critical illness recovery hospital segment adjusted EBITDA $115.9M (+51.0%); margin improved to 17.7%.
Reaffirms 2024 revenue outlook $6.9-7.1B; adjusts EBITDA outlook to $845-885M; adj EPS outlook $1.96-2.20.
Declares cash dividend $0.125 per share, payable May 30, 2024 to holders of record May 16.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

SELECT MEDICAL HOLDINGS CORP reported for its first quarter ended March 31, 2024 results: revenue increased 7.4% to $1,788.8 million, net income increased 37.4% to $117.2 million, EPS increased 33.9% to $0.75.

Period: for its first quarter ended March 31, 2024
Revenue: increased 7.4% to $1,788.8 million
Net income: increased 37.4% to $117.2 million
EPS: increased 33.9% to $0.75
Result: reported results

Exact text from the filing

SEM) today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend. For the first quarter ended March 31, 2024, revenue increased 7.4% to $1,788.8 million, compared to $1,665.0 million for the same quarter, prior year. Income from operations increased 28.1% to $194.0 million for the first quarter ended March

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

SELECT MEDICAL HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001104659-24-056432

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.